Green pharmacy and pharmEcovigilance: prescribing and the planet

References

• Daughton CG, Ruhoy IS. The afterlife of drugs and the role of pharmEcovigilance. Drug Saf.31(12), 1069–1082 (2008).
   PubMedGoogle Scholar
• Daughton CG. Pharmaceuticals as environmental pollutants: the ramifications for human exposure. In: International Encyclopedia of Public Health. Heggenhougen K, Quah S (Eds). Academic Press, Oxford, UK, 66–102 (2008).
   Google Scholar
• Leggett R, Lee-Smith EE, Jickells SM, Russell DA. “Intelligent” fingerprinting: simultaneous identification of drug metabolites and individuals by using antibody-functionalized nanoparticles. Angew. Chem. Int. Ed.46(22), 4100–4103 (2007).
   PubMed Web of Science ®Google Scholar
• Daughton CG, Ruhoy IS. Environmental footprint of pharmaceuticals – the significance of factors beyond direct excretion to sewers. Environ. Toxicol. Chem.28(12), 2495–2521 (2009).
   PubMed Web of Science ®Google Scholar
• Daughton CG. Environmental stewardship and drugs as pollutants. Lancet360(9339), 1035–1036 (2002).
   PubMed Web of Science ®Google Scholar
• Daughton CG, Brooks BW. Active pharmaceutical ingredients and aquatic organisms. In: Environmental Contaminants in Biota: Interpreting Tissue Concentrations. Beyer WN, Meador JP (Eds). Taylor and Francis, Boca Raton, FL, USA 281–340 (2011).
   Google Scholar
• Daughton CG. Groundwater recharge and chemical contaminants: challenges in communicating the connections and collisions of two disparate worlds. Ground Water Monit. Remediat.24(2), 127–138 (2004).
   Google Scholar
• Daughton CG. Pharmaceutical ingredients in drinking water: overview of occurrence and significance of human exposure. In: Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations. Halden RU (Ed.) ACS Symposium Series 1048, American Chemical Society, Washington, DC, USA 9–68 (2010).
   Google Scholar
• Gallagher LG, Webster TF, Aschengrau A, Vieira VM. Using residential history and groundwater modeling to examine drinking water exposure and breast cancer. Environ. Health Perspect.118(6), 749–755 (2010).
   PubMedGoogle Scholar
• Wu C, Spongberg AL, Witter JD, Fang M, Czajkowski KP. Uptake of pharmaceutical and personal care products by soybean plants from soils applied with biosolids and irrigated with contaminated water. Environ. Sci. Technol.44(16), 6157–6161 (2010).
   PubMed Web of Science ®Google Scholar
• Langdon KA, Warne MSJ, Kookana RS. Aquatic hazard assessment for pharmaceuticals, personal care products and endocrine disrupting compounds from biosolids-amended land. Integr. Environ. Assess. Manage.6(4), 663–676 (2010).
   PubMedGoogle Scholar
• Blanco G, Lemus JÁ, Martínez F, Arroyo B, García-Montijano M, Grande J. Ingestion of multiple veterinary drugs and associated impact on vulture health: implications of livestock carcass elimination practices. Anim. Conserv.12(6), 571–580 (2009).
   Web of Science ®Google Scholar
• Kümmerer K. Pharmaceuticals in the environment. Annu. Rev. Environ. Resour.35, 57–75 (2010).
   Web of Science ®Google Scholar
• Corcoran J, Winter MJ, Tyler CR. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit. Rev. Toxicol.40(4), 287–304 (2010).
   PubMed Web of Science ®Google Scholar
• Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect.107(Suppl. 6), 907–938 (1999).
   PubMed Web of Science ®Google Scholar
• Daughton CG. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ. Health Perspect.111(5), 757–774 (2003).
   PubMed Web of Science ®Google Scholar
• Daughton CG. Chemicals from the practice of healthcare: challenges and unknowns posed by residues in the environment. Environ. Toxicol. Chem.28(12), 2490–2494 (2009).
   PubMedGoogle Scholar
• Wishart DS, Knox C, Guo AC et al. DrugBank: a knowledge base for drugs, drug actions and drug targets. Nucleic Acids Res.36(Suppl. 1), D901–D906 (2008).
   PubMed Web of Science ®Google Scholar
• Kolpin DW, Furlong ET, Meyer MT et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ. Sci. Technol.36(6), 1202–1211 (2002).
   PubMed Web of Science ®Google Scholar
• Ramirez AJ, Brain RA, Usenko S et al. Occurrence of pharmaceuticals and personal care products (PPCPs) in fish: results of a national pilot study in the U.S. Environ. Toxicol. Chem.28(12), 2587–2597 (2009).
   PubMed Web of Science ®Google Scholar
• Boxall AB, Johnson P, Smith EJ, Sinclair CJ, Stutt E, Levy LS. Uptake of veterinary medicines from soils into plants. J. Agric. Food Chem.54(6), 2288–2297 (2006).
   PubMed Web of Science ®Google Scholar
• Boonsaner M, Hawker DW. Accumulation of oxytetracycline and norfloxacin from saline soil by soybeans. Sci. Total Environ.408(7), 1731–1737 (2010).
   PubMed Web of Science ®Google Scholar
• Grote M, Schwake-Anduschus C, Michel R et al. Incorporation of veterinary antibiotics into crops from manured soil. Landbauforschung Volkenrode57(1), 25–32 (2007).
   Web of Science ®Google Scholar
• Winker M, Clemens J, Reich M, Gulyas H, Otterpohl R. Ryegrass uptake of carbamazepine and ibuprofen applied by urine fertilization. Sci. Total Environ.408(8), 1902–1908 (2010).
   PubMedGoogle Scholar
• Kinney CA, Furlong ET, Kolpin DW et al. Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environ. Sci. Technol.42(6), 1863–1870 (2008).
   PubMed Web of Science ®Google Scholar
• De Lange HJ, Noordoven W, Murk AJ, Lurling M, Peeters ETHM. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat. Toxicol.78(3), 209–216 (2006).
   PubMed Web of Science ®Google Scholar
• Guler Y, Ford AT. Anti-depressants make amphipods see the light. Aquat. Toxicol.90(3), 397–404 (2010).
   Google Scholar
• Kidd KA, Blanchfield PJ, Mills KH et al. Collapse of a fish population after exposure to a synthetic estrogen. Proc. Natl Acad. Sci.104(21), 8897–8901 (2007).
   PubMed Web of Science ®Google Scholar
• Daughton CG. Emerging chemicals as pollutants in the environment: a 21st century perspective. Renewable Resources J.23(4), 6–23 (2005).
   Google Scholar
• Keil F. Pharmaceuticals for human use: an integrated strategy for reducing the contamination of water bodies. In: Green and Sustainable Pharmacy. Kümmerer K, Hempel M (Eds). Springer-Verlag, Berlin Heidelberg, Germany, 225–241 (2010).
   Google Scholar
• Enick OV, Moore MM. Assessing the assessments: pharmaceuticals in the environment. Environ. Impact Assess. Rev.27(8), 707–729 (2007).
   Web of Science ®Google Scholar
• Martin OV, Voulvoulis N. Sustainable risk management of emerging contaminants in municipal wastewaters. Philos. Transact. A Math. Phys. Eng. Sci.367(1904), 3895–3922 (2009).
   PubMedGoogle Scholar
• Anon. Rational use of medicines. Lancet375(9731), 2052 (2010).
   Web of Science ®Google Scholar
• Wennmalm Å, Gunnarsson B. Pharmaceutical management through environmental product labeling in Sweden. Environ. Int.35(5), 775–777 (2009).
   PubMedGoogle Scholar
• Zuccato E, Calamari D, Natangelo M, Fanelli R. Presence of therapeutic drugs in the environment. Lancet355(9217), 1789–1790 (2000).
   PubMed Web of Science ®Google Scholar
• Reiter L, Falk H, Groat C, Coussens CM (Eds). From Source Water to Drinking Water: Workshop Summary, National Academies Press, Washington, DC, USA, 126 (2004).
   Google Scholar
• Jacobziner H, Raybin HW. Improper disposal of drugs and household products. NY State J. Med.59, 3631–3634 (1959).
   PubMedGoogle Scholar
• Nicholson WA. Collection of unwanted drugs from private homes. Br. Med. J.3(5567), 730–731 (1967).
   PubMedGoogle Scholar
• Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch. Intern. Med.170(9), 749–750 (2010).
   PubMed Web of Science ®Google Scholar
• Wright GD. Q&A: Antibiotic resistance: where does it come from and what can we do about it? BMC Biol.8(1), 123 (2010).
   PubMedGoogle Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. DOI: 10.1073/pnas.1000087107 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol.10(10), 735–744 (2010).
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. Disposal of controlled substances by persons not registered with the drug enforcement administration [Advance Notice of Proposed Rulemaking]. Fed. Regist.74(12), 3480–3487 (2009).
   Google Scholar
• Delbanco T, Walker J, Darer JD et al. Open notes: doctors and patients signing on. Ann. Intern. Med.153(2), 121–125 (2010).
   PubMed Web of Science ®Google Scholar
• Dentzer S. Thematic issue: comparative effectiveness research. Health Aff.29(10), 1756–1919 (2010).
   Google Scholar
• Barman I, Kong C-R, Singh GP, Dasari RR, Feld MS. Accurate spectroscopic calibration for noninvasive glucose monitoring by modeling the physiological glucose dynamics. Anal. Chem.82(14), 6104–6114 (2010).
   PubMed Web of Science ®Google Scholar
• James TH, Helms ML, Braund R. Analysis of medications returned to community pharmacies. Ann. Pharmacother.43(10), 1631–1635 (2009).
   PubMedGoogle Scholar
• Daughton CG, Ruhoy IS. Reducing the ecological footprint of pharmaceutical usage: linkages between healthcare practices and the environment. In: Green and Sustainable Pharmacy. Kümmerer K, Hempel M (Eds). Springer-Verlag, Berlin Heidelberg, Germany, 77–102 (2010).
   Google Scholar
• Kesselheim AS, Outterson K. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals. Health Aff.29(9), 1689–1696 (2010).
   PubMed Web of Science ®Google Scholar
• Cressey D. Tiny traits cause big headaches: nanotech medicines held up by lack of particle characterization. Naturenews467, 264–265 (2010).
   Google Scholar
• van Baarlen P, Troost F, van der Meer C et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl Acad. Sci. DOI: 10.1073/pnas.1000079107 (2010) (Epub ahead of print).
   Google Scholar
• Sox HC. Comparative effectiveness research: a progress report. Ann. Intern. Med.153(7), 469–472(2010).
   PubMed Web of Science ®Google Scholar
• Kotler P, Zaltman G. Social marketing: an approach to planned social change. J. Mark.85, 3–12 (1971).
   Google Scholar
• Glassmeyer ST, Hinchey EK, Boehme SE et al. Disposal practices for unwanted residential medications in the United States. Environ. Int.35(3), 566–572 (2009).
   PubMed Web of Science ®Google Scholar
• Daughton CG, Ruhoy IS. Accumulation and disposal of leftover medications: a key aspect of pharmEcovigilance. In: An Introduction to Environmental Pharmacology. Rahman SZ, Shahid M, Gupta V (Eds). Ibn Sina Academy, Aligarh, India, 101–107 (2008).
   Google Scholar
• Ruhoy IS, Daughton CG. Beyond the medicine cabinet: an analysis of where and why medications accumulate. Environ. Int.34(8), 1157–1169 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenow ECI. Patients’ understanding of and compliance with medications: the sixth vital sign? Mayo Clin. Proc.80(8), 983–987 (2005).
   PubMedGoogle Scholar
• Fincham JE. Patient Compliance with Medications: Issues and Opportunities Pharmaceutical Products Press, The Haworth Press, Inc., Binghamton, NY, USA, 232 (2007).
   Google Scholar
• Kleinsinger F. Working with the noncompliant patient. Perm. J.14(1), 54–60 (2010).
   PubMedGoogle Scholar
• Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc. Sci. Med.61(1), 133–155 (2005).
   PubMed Web of Science ®Google Scholar